ONCOTICE

This brand name is authorized in Austria, Australia, Canada, Cyprus, Spain, Israel, New Zealand, Poland, Turkey, United Kingdom

Active ingredients

The drug ONCOTICE contains one active pharmaceutical ingredient (API):

1 Bacillus Calmette-Guerin (BCG strain Tice) UNII XZQ806VFEO - MYCOBACTERIUM BOVIS

BCG vaccine is an immunostimulating agent. It has anti-tumor activity, but the exact mechanism of action is not known. Read about BCG vaccine

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
ONCOTICE Powder for instillation fluid for intravesical use	Medicines & Healthcare Products Regulatory Agency (GB)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
L03AX03	BCG vaccine	L Antineoplastic and immunomodulating agents → L03 Immunostimulants → L03A Immunostimulants → L03AX Other immunostimulants
Discover more medicines within L03AX03

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: AU	Pharmaceutical Benefits Scheme	Identifier(s): 1131M, 5902P
Country: CA	Health Products and Food Branch	Identifier(s): 02153513
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 61377
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 80691
Country: IL	מִשְׂרַד הַבְּרִיאוּת	Identifier(s): 8564
Country: NZ	Medicines and Medical Devices Safety Authority	Identifier(s): 6143
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100195800
Country: TR	İlaç ve Tıbbi Cihaz Kurumu	Identifier(s): 8699636790403